| Inflammaging |
498 |
16-nov-2026 |
|
| Cellular Senescence |
434 |
16-nov-2026 |
|
| Mitochondrial Dysfunction |
344 |
16-nov-2026 |
|
| Vascular Aging |
180 |
16-nov-2026 |
|
| Immunosenescence |
176 |
16-nov-2026 |
|
| mTOR and Nutrient Sensing |
165 |
16-nov-2026 |
|
| Autophagy |
136 |
16-nov-2026 |
|
| DNA Methylation and Epigenetic Aging |
128 |
16-nov-2026 |
|
| Gut Microbiota and Healthspan |
103 |
16-nov-2026 |
|
| Menopause and Estrogen Decline as a Primary Aging Driver |
70 |
13-nov-2026 |
|
| Telomeres |
50 |
16-nov-2026 |
|
| Sirtuin-1 (SIRT1) and Sirtuins |
48 |
13-nov-2026 |
|
| PINK1–Parkin Mitophagy and Mitochondrial Ubiquitination |
38 |
16-nov-2026 |
|
| cGAS–STING DNA Sensing |
29 |
13-nov-2026 |
|
| FoxO Transcription Factors |
26 |
16-nov-2026 |
|
| ER Unfolded Protein Response (UPR) |
19 |
13-nov-2026 |
|
| Aging Omic Biomarkers and Clocks |
16 |
16-nov-2026 |
|
| Ferroptosis |
16 |
16-nov-2026 |
|
| Partial Reprogramming |
11 |
07-oct-2026 |
|
| Actin Cytoskeleton in Aging |
10 |
15-nov-2026 |
|
| Wnt/β-Catenin Signaling in Aging |
10 |
07-oct-2026 |
|
| Gut Microbiota–Bile Acid–FXR–FGF15 Muscle Axis |
9 |
10-nov-2026 |
|
| Gut–Liver–Heart Bile Acid Axis in Aging CAD |
8 |
07-oct-2026 |
|
| Gut Microbiota–Bone Axis |
7 |
10-nov-2026 |
|
| Gut Microbiota–Citrulline Metabolism in Metabolic Aging |
6 |
16-nov-2026 |
|
| Stem Cell Exhaustion and Stem Cell-Based Interventions |
3 |
16-nov-2026 |
|
| Genomic Instability |
3 |
10-nov-2026 |
|
| Bone Marrow Adipose Tissue (BMAT) and Marrow Adipocytes |
3 |
11-oct-2026 |
|
| Extracellular Vesicles in Aging |
2 |
05-oct-2026 |
|
| SUMOylation as Metabolic Stress Sensor in Aging |
2 |
28-sep-2026 |
|
| Bat Comparative Longevity Genomics |
2 |
13-sep-2026 |
|
| Antagonistic Pleiotropy and the Adaptive Cost of Aging |
2 |
13-sep-2026 |
|
| Clonal Hematopoiesis |
2 |
09-sep-2026 |
|
| Growth Hormone / IGF-1 Axis in Aging |
2 |
09-sep-2026 |
|
| Irisin/FNDC5–BDNF Muscle–Brain Signaling |
2 |
09-sep-2026 |
|
| Comparative Biology of Longevity |
1 |
16-nov-2026 |
|
| Hormesis in Aging |
1 |
10-nov-2026 |
|
| Osteoblast Glycolytic Decline in Bone Aging |
1 |
10-nov-2026 |
|
| Childhood Development Rate and Pace of Aging |
1 |
11-oct-2026 |
|
| Aging Purinome (Purinergic Signaling in Aging) |
1 |
11-oct-2026 |
|
| Biological Age Uncertainty (BAU) |
1 |
07-oct-2026 |
|
| tRNA Modifications and CCA-Tail Dynamics in Aging |
1 |
07-oct-2026 |
|
| Age-Related Hearing Loss and Blood-Labyrinth Barrier |
1 |
07-oct-2026 |
|
| Muscle Stem-Cell Niche Aging |
1 |
07-oct-2026 |
|
| Tissue Homeostasis and Blastema-Mediated Regeneration |
1 |
07-oct-2026 |
|
| Stem Cell Exhaustion and Regenerative Decline |
1 |
07-oct-2026 |
|
| Pancreatic α-Cell Aging and Hyperglucagonemia |
1 |
07-oct-2026 |
|
| Deregulated Nutrient Sensing in Aging |
1 |
07-oct-2026 |
|
| Ghrelin–SHBG–JNK1–Beclin1 Microglial Autophagy Axis in Cognitive Aging |
1 |
07-oct-2026 |
|
| Endothelial TLR4 in Vascular Senescence and Targeted Senotherapeutics |
1 |
07-oct-2026 |
|
| Adult Neurogenesis and Neuroplasticity in Aging |
1 |
07-oct-2026 |
|
| GABAergic Cortical Inhibition in Aging |
1 |
07-oct-2026 |
|
| Fibro/Adipogenic Progenitors and Intramuscular Adipogenesis |
1 |
07-oct-2026 |
|
| Muscle Stem Cell Exhaustion and Niche Failure |
1 |
07-oct-2026 |
|
| Satellite Cell Niche Disruption in Muscle Aging |
1 |
07-oct-2026 |
|
| Vestibular Aging and Central Neural Gain Compensation |
1 |
07-oct-2026 |
|
| LRRK2 as a Multisystem Regulator of Aging |
1 |
07-oct-2026 |
|
| Biological Limits of Lifespan Extension |
1 |
07-oct-2026 |
|
| Chaperone-Mediated Autophagy (CMA) |
1 |
07-oct-2026 |
|
| Testicular Aging and the SSC–Macrophage CXCL13 Axis |
1 |
07-oct-2026 |
|
| PRMT-Mediated Arginine Methylation |
1 |
07-oct-2026 |
|
| Cerebral Amyloid-β Pathology in Aging |
1 |
07-oct-2026 |
|
| Sweet Taste T1R2/T1R3 Signaling in Energy Homeostasis |
1 |
07-oct-2026 |
|
| Brain Maintenance and Cognitive Reserve |
1 |
05-oct-2026 |
|
| Mitochondria-Associated ER Membranes (MAMs) and Calcium Exchange |
1 |
05-oct-2026 |
|
| AGE-RAGE Pathway in Aging and Neurodegeneration |
1 |
05-oct-2026 |
|
| Hematopoietic Stem Cell Aging |
1 |
05-oct-2026 |
|
| Centenarian Biology and Exceptional Longevity |
1 |
05-oct-2026 |
|
| Nutrition–Sleep–Circadian Axis in Neurodegeneration |
1 |
05-oct-2026 |
framing-only
|
| Cardiolipin and CRLS1 in Muscle Aging |
1 |
05-oct-2026 |
|
| NLRP3 Inflammasome in Aging and Neurodegeneration |
1 |
05-oct-2026 |
awaiting-synthesis
|
| Brain Aging Clocks |
1 |
05-oct-2026 |
|
| Epigenetic Immune Transition Windows |
1 |
05-oct-2026 |
|
| Lysine Lactylation (Kla) in Ageing |
1 |
05-oct-2026 |
|
| Elastin Fragments and ECM Aging |
1 |
05-oct-2026 |
|
| Circulating Senosome |
1 |
05-oct-2026 |
|
| Muscle–Brain Axis and Myokines |
1 |
05-oct-2026 |
|
| Amyloid Beta as a Driver of Brain Inflammaging |
1 |
05-oct-2026 |
|
| Chronic Subdural Hematoma as a Geroscience Disease |
1 |
05-oct-2026 |
|
| Thymic Involution and Regeneration |
1 |
05-oct-2026 |
|
| Hepatic Growth Hormone Receptor Signaling in Aging |
1 |
05-oct-2026 |
|
| Bile Acid–FXR–TGR5 Axis in Hepatic Aging |
1 |
05-oct-2026 |
|
| Epstein-Barr Virus Latency as a Stress Test of Aging Immune Surveillance |
1 |
05-oct-2026 |
|
| Thymic Involution and Thymic Output |
1 |
05-oct-2026 |
|
| FAHFA Lipokines and Adipose Aging |
1 |
04-oct-2026 |
|
| Extracellular Vesicles and Hippocampal Homeostasis |
1 |
04-oct-2026 |
|
| Muscle–Bone–Adipose Crosstalk in Disuse |
1 |
04-oct-2026 |
|
| Cerebellar Functional Network Aging |
1 |
04-oct-2026 |
|
| lncRNA H19 in Osteoblast Aging |
1 |
04-oct-2026 |
|
| Oocyte Meiotic SAC Weakening and Chromosome Segregation Aging |
1 |
28-sep-2026 |
|
| Locus Coeruleus and Noradrenergic Aging |
1 |
28-sep-2026 |
|
| Specialized Pro-Resolving Mediators (SPMs) and Inflammation Resolution |
1 |
28-sep-2026 |
|
| Life-Course Antecedents of Aging |
1 |
28-sep-2026 |
|
| Hematopoietic Progenitor Cell Aging |
1 |
28-sep-2026 |
|
| Comparative Biology of Long-Lived Species |
1 |
28-sep-2026 |
|
| Naked Mole Rat Hyaluronan (HAS2) and ECM Longevity |
1 |
28-sep-2026 |
|
| Programmed and Adaptive Cognitive Aging |
1 |
28-sep-2026 |
|
| Cancer Suppression in Long-Lived Species |
1 |
28-sep-2026 |
|
| α-Synuclein and Proteostasis in Neurodegeneration |
1 |
28-sep-2026 |
|
| Neural Hyperexcitability in Aging |
1 |
28-sep-2026 |
|
| Growth Hormone Receptor Signaling in Aging |
1 |
28-sep-2026 |
|
| Gut–Brain Axis and Cachexia-like Metabolic Reprogramming |
1 |
28-sep-2026 |
|
| Hematopoietic Stem Cell Aging (BIRC6 Axis) |
1 |
28-sep-2026 |
|
| Plasma Metal Exposure and Biological Aging |
1 |
28-sep-2026 |
|
| Sex-Specific Organ-System Aging Clocks |
1 |
28-sep-2026 |
|
| Stress Granules and Liquid-Liquid Phase Separation |
1 |
28-sep-2026 |
|
| Hepassocin (HPS) as an Age-Declining Hepatokine |
1 |
28-sep-2026 |
|
| NAMPT and NAD Biosynthesis in Aging |
1 |
28-sep-2026 |
|
| Adipose Thermogenesis and Beige/Brown Fat Identity |
1 |
28-sep-2026 |
|
| Conserved Longevity Pathways Across Species |
1 |
28-sep-2026 |
|
| Calcium Signaling Fidelity in Aging |
1 |
28-sep-2026 |
|
| Cuproptosis |
1 |
28-sep-2026 |
|
| Mitochondria-Associated ER Membranes (MAMs) |
1 |
28-sep-2026 |
|
| Heme Oxygenase-1 (HO-1) in Aging |
1 |
28-sep-2026 |
|
| Asb2–KIF11 Axis in Cardiomyocyte Autophagy and Cardiac Aging |
1 |
28-sep-2026 |
|
| Pin1–cis P-tau Axis |
1 |
28-sep-2026 |
|
| AGE–RAGE Glycative Stress in Aging |
1 |
28-sep-2026 |
|
| Paternal Germline Aging and Redox Homeostasis |
1 |
28-sep-2026 |
|
| Bone Aging (Multiscale Degeneration) |
1 |
28-sep-2026 |
|
| ATM DNA-Damage Response and LSD1 Demethylation |
1 |
28-sep-2026 |
|
| Mechanotransduction and Mechanical Drift in Aging |
1 |
27-sep-2026 |
|
| AT2 Receptor (AT2R) in Cardiac Aging and Senescence |
1 |
27-sep-2026 |
|
| Type H Vessels and Angiogenic–Osteogenic Coupling |
1 |
27-sep-2026 |
|
| Cardiovascular Frailty |
1 |
27-sep-2026 |
|
| Oral Microbiome–Periodontitis Inflammaging Axis |
1 |
27-sep-2026 |
|
| Cardiac Lymphatic Rarefaction and Aging |
1 |
27-sep-2026 |
|
| B-Cell Aging, Tolerance Failure, and Age-Associated B Cells (ABCs) |
1 |
27-sep-2026 |
|
| Biological Self-Correction and Dynamic Recovery |
1 |
27-sep-2026 |
|
| Brain–Muscle Axis in Aging |
1 |
27-sep-2026 |
|
| Nrf2 and Oxidative Stress Response in Aging |
1 |
27-sep-2026 |
|
| CISD2 Longevity Pathway |
1 |
27-sep-2026 |
|
| Selenoproteins in Muscle Aging and Sarcopenia |
1 |
20-sep-2026 |
|
| Adipose–Brain Aging Axis |
1 |
20-sep-2026 |
|
| Hepatic ACAT3 in Cholesterol–Bile Acid–Microbiota Signaling |
1 |
20-sep-2026 |
|
| Ovarian Stromal Fibrosis and Reproductive Aging |
1 |
20-sep-2026 |
|
| GLP-1 Receptor Agonists as Candidate Geroprotectors |
1 |
20-sep-2026 |
|
| Gingival Tissue Aging |
1 |
13-sep-2026 |
|
| Bat Longevity Genomics |
1 |
13-sep-2026 |
|
| Muscle Calcium Handling in Aging |
1 |
13-sep-2026 |
|
| Stochastic Damage Accumulation and Inter-Individual Aging Variance |
1 |
13-sep-2026 |
|
| Dendritic Cell Antigen Presentation and T-Cell Brain Entry in Tau Pathology |
1 |
13-sep-2026 |
|
| Senescent Cell Adhesion Fragments (SCAFs) |
1 |
13-sep-2026 |
|
| C3a–C3AR1 Complement Signalling in Aging |
1 |
13-sep-2026 |
|
| Trained Immunity and Trained Tolerance |
1 |
13-sep-2026 |
emerging
|
| Apo(a)-Rich Electronegative HDL (H5) in Vascular Aging |
1 |
13-sep-2026 |
|
| Bone Marrow Adiposity and Osteoblast–Adipocyte Fate |
1 |
13-sep-2026 |
|
| SKN-1/Nrf2 Detoxification Pathway |
1 |
10-sep-2026 |
|
| MAPK/JNK Signaling and Tau Phosphorylation |
1 |
10-sep-2026 |
|
| Comparative Mammalian Longevity Genomics |
1 |
10-sep-2026 |
|
| Anemia of Aging and Unexplained Anemia in the Elderly |
1 |
10-sep-2026 |
|
| Human Aging Characterization |
1 |
10-sep-2026 |
|
| Physiological Resilience in Aging |
1 |
10-sep-2026 |
|
| Corticospinal and Reticulospinal Tract Aging |
1 |
10-sep-2026 |
|
| Muscle C-Protein (MyBP-C) in Aging |
1 |
10-sep-2026 |
|
| Familial Longevity Genetics |
1 |
10-sep-2026 |
|
| Progerin and Lamin A Nuclear Lamina Defects |
1 |
10-sep-2026 |
|
| Copper and Iron Metabolic Programs for Cellular Survival |
1 |
10-sep-2026 |
|
| TWEAK/Fn14 Signaling in Muscle Aging |
1 |
10-sep-2026 |
|
| Myokines in Muscle Aging |
1 |
09-sep-2026 |
|
| Noradrenergic System Aging |
1 |
09-sep-2026 |
|
| Brain Glucose Metabolism Decline in Aging |
1 |
09-sep-2026 |
|
| Centenarian Biology and Extreme Longevity |
1 |
09-sep-2026 |
|
| Compensatory Brain Network Dynamics in Aging |
1 |
09-sep-2026 |
|
| Brain Energy Metabolism in Aging |
1 |
09-sep-2026 |
|
| Alpha-Gamma Phase-Amplitude Coupling in Aging Vision |
1 |
09-sep-2026 |
|
| Neuroplasticity in Aging |
1 |
09-sep-2026 |
|
| Body Fluid Distribution Changes with Aging |
1 |
09-sep-2026 |
|
| Extracellular Matrix Aging |
1 |
09-sep-2026 |
|
| Associative and Episodic Memory Aging |
1 |
09-sep-2026 |
|
| Altered Intercellular Communication (Extracellular Vesicles) |
1 |
09-sep-2026 |
|
| Companion Dog Aging as a Human Translational Model |
1 |
09-sep-2026 |
|
| Age-Related Taste Dysfunction |
1 |
09-sep-2026 |
|
| Hair Cell Aging and Age-Related Hearing Loss |
1 |
09-sep-2026 |
|
| Piezo1–Connexin 43 Bone Mechanotransduction |
1 |
09-sep-2026 |
|
| Age-Related Transcriptional Reprogramming |
1 |
09-sep-2026 |
|
| Tissue Repair Capacity in Aging |
1 |
09-sep-2026 |
|
| Oxygenaging (Oxygen Physiology Framework) |
1 |
09-sep-2026 |
|
| ATIP / AT2 Signaling and Amyloid Pathology |
1 |
09-sep-2026 |
|
| Hutchinson-Gilford Progeria Syndrome (HGPS) |
1 |
09-sep-2026 |
|
| GH/IGF-1 Signaling in Aging |
1 |
09-sep-2026 |
|
| Circadian Clock Genes in Aging (Timeless) |
1 |
09-sep-2026 |
|
| Oxidative Stress and ROS Signaling |
1 |
09-sep-2026 |
|
| Sarcopenia as a Multi-Organ Metabolic-Inflammatory (GLAM) Axis |
1 |
09-sep-2026 |
|
| H3K27 Acetylation |
1 |
09-sep-2026 |
|
| RNA-Binding Proteins in Aging |
1 |
09-sep-2026 |
|
| FUBL-3/FUBP1 Chromatin Remodeling under Mitochondrial Stress |
1 |
09-sep-2026 |
|
| Renal Aging (Podocyte mPGES-2) |
1 |
09-sep-2026 |
|
| YAP1/Hippo Signaling in Senescence and Fibrosis |
1 |
09-sep-2026 |
|
| Nuclear Lamina and Progerin in Premature Aging |
1 |
09-sep-2026 |
|
| Ocular Aging |
1 |
09-sep-2026 |
awaiting-synthesis
|
| ASAP3–Actin–Autophagy Hepatic Senescence Axis |
1 |
09-sep-2026 |
|
| Spinal Aging and Degenerative Spinal Disease |
1 |
09-sep-2026 |
|
| Citrulline–Lipogenesis Axis in Aging |
1 |
09-sep-2026 |
|
| Bone Marrow and Hematopoietic Aging |
1 |
09-sep-2026 |
|
| Lamtor5–ESCRT–cGAS Macrophage Immunosenescence Axis |
1 |
09-sep-2026 |
|
| Theca Cells as Orchestrators of Ovarian Aging |
1 |
09-sep-2026 |
|
| Hepatic Ammonia Metabolism in Aging |
1 |
09-sep-2026 |
|
| Complosome (Intracellular Complement) |
1 |
09-sep-2026 |
|
| Osteoimmune Senescence in Skeletal Aging |
1 |
09-sep-2026 |
|
| Physical Senotype and Mechanical Senotherapy |
1 |
09-sep-2026 |
|
| Neurovascular Interface in Aging |
1 |
09-sep-2026 |
|
| Cbfβ–Marrow Adipoq⁺ Cell Axis in Skeletal Stem Cell Maintenance |
1 |
09-sep-2026 |
|
| Aquaporin and Water Homeostasis in Aging |
1 |
09-sep-2026 |
|
| Damage-Driven Aging Theory |
1 |
09-sep-2026 |
|
| Programmed Aging Theory |
1 |
09-sep-2026 |
|
| Longevity Polygenic Risk |
1 |
09-sep-2026 |
|
| HIF-1α in Metabolic Aging |
1 |
09-sep-2026 |
|
| Oral Microbiota and the Oral–Brain Axis |
1 |
09-sep-2026 |
|
| Mitochondrial Unfolded Protein Response (UPRmt) |
1 |
09-sep-2026 |
|
| Microbiome Age and the Microbiome–Chronological Age Gap |
1 |
09-sep-2026 |
|
| Ovarian Aging and Premature Ovarian Insufficiency Mechanisms |
1 |
09-sep-2026 |
|
| VSMC Phenotypic Plasticity in Atherosclerosis |
1 |
09-sep-2026 |
|
| Mitochondria–ER Contact Sites (MERCS/MAM) |
1 |
09-sep-2026 |
|
| LAPTM5–WWP2–OPTN Mitophagy Axis in RPE Aging |
1 |
09-sep-2026 |
|
| SIRT6 in Longevity and Progeria |
1 |
09-sep-2026 |
|
| Sex-Dimorphic Hormonal Signaling in Sarcopenia (Apelin–Insulin–Oxytocin) |
1 |
09-sep-2026 |
|
| Epigenetic Regulation in Muscle Aging |
1 |
09-sep-2026 |
|
| Splicing Degeneration (RNA Splicing Fidelity in Aging) |
1 |
09-sep-2026 |
|
| Klotho |
1 |
09-sep-2026 |
|
| SIRT5–SUCLG2 Desuccinylation Axis |
1 |
09-sep-2026 |
|
| NuA4/TIP60 Developmental Proteostasis Priming |
1 |
09-sep-2026 |
|
| Protein Palmitoylation in Cardiovascular Aging |
1 |
09-sep-2026 |
|
| Vascular Mechanotransduction and Coronary Remodeling |
1 |
09-sep-2026 |
|
| MG29/SYPL2, Triad Membrane Cholesterol, and SOCE in Muscle Aging |
1 |
09-sep-2026 |
|
| TLRs–SAPS2/PPP6C–NF-κB Senescence Axis |
1 |
09-sep-2026 |
|
| METTL13–Foxa1–HES-1 Axis in BMSC Senescence |
1 |
09-sep-2026 |
|
| BCAP31–POLR1E–CD44 Senescence Axis |
1 |
09-sep-2026 |
|
| Light-Based Aging Models (PDT and Optogenetics) |
1 |
09-sep-2026 |
|
| PRMT6–FOXG1–Mitophagy Axis in Cochlear Aging |
1 |
09-sep-2026 |
|
| TIMP2–ECM–Microglia Axis in Brain Aging |
1 |
09-sep-2026 |
|
| EDC-Driven DNA Methylation Reprogramming |
1 |
09-sep-2026 |
|
| ANGPTL8–AKT2–mTOR Adipose Senescence Axis |
1 |
09-sep-2026 |
single-report
|
| RTE and Heterochromatin Derepression |
1 |
09-sep-2026 |
|
| Reductive Stress |
1 |
09-sep-2026 |
|
| Epigenetic Skeletal Muscle Memory |
1 |
09-sep-2026 |
|
| Comparative Biology of Longevity |
0 |
08-sep-2026 |
awaiting-synthesis
|